The 2025 IPO Market
JD Supra: Mergers
DECEMBER 19, 2024
Are we headed for an IPO rebound in 2025? According to a recent CNBC article, a major window for the IPO market could be opening.
JD Supra: Mergers
DECEMBER 19, 2024
Are we headed for an IPO rebound in 2025? According to a recent CNBC article, a major window for the IPO market could be opening.
JD Supra: Mergers
JANUARY 9, 2025
The outlook for life sciences IPOs is showing renewed optimism heading into 2025, with market conditions becoming more constructive and regulatory environments potentially more favorable. By: Fenwick & West LLP
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
JD Supra: Mergers
DECEMBER 16, 2024
The life sciences industry is well positioned for growth in 2025, fueled by strong investor interest and technological advancements, especially in AI. Life sciences venture capital (VC) funding and IPOs have picked up in 2024, and anticipated Federal Reserve interest rate cuts will likely further accelerate this trend. By: Goodwin
Global Banking & Finance
SEPTEMBER 11, 2024
By Hadeel Al Sayegh, Andres Gonzalez and Federico Maccioni DUBAI/LONDON (Reuters) -Abu Dhabi’s Etihad Airways plans to make its stock market debut no sooner than 2025, two people familiar with the matter said, in potentially the first IPO of a major Gulf airline as the UAE’s capital ramps up effort to become a global travel […]
Global Banking & Finance
DECEMBER 2, 2024
By Joanna Plucinska LONDON (Reuters) -AirBaltic is pushing its planned initial public offering back to the first half of 2025 or later as its advisers suggest waiting for improved market conditions in the European sector.
Global Newswire by Notified: M&A
JANUARY 15, 2025
15, 2025 (GLOBE NEWSWIRE) -- BurTech Acquisition Corp. and began trading on Nasdaq under the ticker symbols BZAI and BZAIW on January 14, 2025. WASHINGTON and EL DORADO HILLS, Calif., BurTech) (NASDAQ: BRKH), a publicly traded special purpose acquisition company, and Blaize, Inc.
iMerge Advisors
APRIL 10, 2025
Theyre often engaged by public companies or unicorns seeking IPO alternatives or strategic exits. Firms like Goldman Sachs , Morgan Stanley , and J.P. Morgan bring unmatched reach and capital markets expertise. However, these firms typically focus on deals with enterprise values above $500 million.
Let's personalize your content